SBIR/STTR Research Award

Development of an autodissemination station for control of mosquito vectors

Award identifier 63f823146ff5f58c73bf50dbc53b1fac07a8393d8059030c56ae76f503d7848bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$149,875

Program and phase

SBIR · Phase I

Award year

2012

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BANFIELDBIO INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
JNAJTN8L1SA4
Solicitation number
PA11-096
Topic code
NIAID

Research abstract

DESCRIPTION (provided by applicant): Autodissemination is a novel technique for insect control whereby target insects spread insecticide to their own habitats through their innate behaviors: a small treatment area results in far wider and target-specific coverage. This concept shows high potential for improved control of urban container-breeding mosquitoes, many of which vector deadly or debilitating diseases, such as dengue, Chikungunya and yellow fever, and also hamper outdoor activity through incessant biting behaviors. These peridomestic mosquitoes are problematic to manage with the aerial spray and fogging regimes typically used by vector control. As container-breeding mosquitoes continue to expand their distribution, dengue and other mosquito-borne pathogens have risen globally. It is imperative that new tools be explored to suppress vector populations and mitigate disease transmission at a landscape level. This project evaluates the feasibility of using autodissemination in a novel device for operational mosquito control against both Aedes albopictus and Aedes aegypti. Prototype autodissemination devices, or stations, will be conceived, designed and evaluated for control of Ae. aegypti and Ae. albopictus, container-breeding vector species now infesting all non-Antarctic continents. As they seek small containers in which to lay their eggs, gravid female mosquitoes will visit the stations and pick up a powdered material containing an insect growth regulator (IGR). Insect growth regulators specificallytarget the hormonal pathways critical to insect development and are essentially non-toxic to vertebrates. The target mosquito species exhibit what is known as skip oviposition, meaning that they deposit eggs from a single clutch in multiple containers.That skipping behavior increases the likelihood that females visiting the station will subsequently visit other breeding sites, such as tree holes or buckets, and inoculate the water in those areas with tiny, but lethal doses of the IGR. All immaturemosquitoes in those treated sites will not become viable adults capable of vectoring disease. To maximize field efficacy and minimize the labor and costs involved in use, features of the ideal final design will include: zero maintenance once deployed; lowcost; full biodegradability; high attraction to the target mosquitoes; extended water retention and attraction through dry periods; high toxicant loading on visiting mosquitoes; and low environmental risk. Prototype stations and IGR formulations will be tested against live mosquitoes to optimize attractancy, water retention, field durability, extended efficacy, and transfer to and from mosquitoes. High potential candidate designs will be evaluated in small cage (1m3) bioassays to validate transfer betweenthe station and other breeding containers via the mosquitoes. Autodissemination from the final prototype will be tested in replicated room (35m3) bioassays. The final prototype will be suitable for large- scale field testing in Phase II in a cooperativeproject with the Rutgers Center for Vector Biology PUBLIC HEALTH RELEVANCE: The proposed research will evaluate a simple, low-cost device with high potential to control populations of container-breeding mosquitoes worldwide, thereby lessening a global disease threat and outdoor nuisance. This device will provide a novel and highly-effective means to target the primary vectors of dengue fever, Chikungunya and West Nile virus and be suitable for cost-effective use around the globe with minimal risk to human beings, non-target animals or the surrounding environment.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

7 SBIR/STTR records share this UEI (2012–2022). Reported award amounts total $6,805,595. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services, Department of Agriculture

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.